Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 210,812 $ 78,297
Accounts receivable 13,056 4,500
Prepaid expenses and other current assets 467 2,105
Total current assets 224,335 84,902
Property, plant and equipment, net 117,118 61,257
Deferred engineering costs 110,025 110,499
Non-current restricted cash 0 3,440
Other non-current assets 32,399 32,897
Total assets 483,877 292,995
Current liabilities:    
Accounts payable 27,861 23,573
Accounts payable due to related parties 0 910
Accrued and other liabilities 35,203 22,003
Borrowings 0 72,819
Total current liabilities 63,064 119,305
Borrowings 0 38,275
Other non-current liabilities 61,612 26,325
Total long-term liabilities 61,612 64,600
Stockholders’ equity:    
Preferred stock, $0.01 par value, 100,000,000 authorized: 6,123,782 and 6,123,782 shares outstanding, respectively 61 61
Common stock, $0.01 par value, 800,000,000 authorized: 470,813,044 and 354,315,739 shares outstanding, respectively 4,477 3,309
Additional paid-in capital 1,244,500 922,042
Accumulated deficit (889,837) (816,322)
Total stockholders’ equity 359,201 109,090
Total liabilities and stockholders’ equity $ 483,877 $ 292,995